Some baseline patient factors, such as biomarkers, are useful in predicting patients’ responses to a new therapy. Identification of such factors is important in enhancing treatment outcomes, avoiding potentially toxic therapy that is destined to fail and improving the cost-effectiveness of...

It has long been recognized that covariate adjustment can increase precision in randomized experiments, even when it is not strictly necessary. Adjustment is often straightforward when a discrete covariate partitions the sample into a handful of strata, but becomes more involved with even a...

Simulation of realistic censored survival times is challenging. Most research studies use highly simplified models, such as the exponential, that do not adequately reflect the patterns of time to event and censoring seen in real datasets. In this article, I present a general method of simulating...

Although we did not find any statistical significant differences in health care costs, we did observe a higher consumption of prescribed medication and lower costs of work hours lost if both patient and GPs participated in a former clinical trial. The results may be limited due to a lower number...

Ranked set sampling (RSS) is a technique for incorporating auxiliary (concomitant) information into estimation and testing procedures right at the design stage. In this paper, we propose group sequential testing procedures for comparing two treatments with binary outcomes under an RSS scheme...

In this article we consider the sample size determination problem in the context of robust Bayesian parameter estimation of the Bernoulli model. Following a robust approach, we consider classes of conjugate Beta prior distributions for the unknown parameter. We assume that inference is robust if...

Experimental design represents the typical context in which the interplay between Bayesian and frequentist methodology is natural and useful. Before the data are observed, it is licit and unavoidable even for a Bayesian statistician to take into account sample variability for the evaluation of...

The accounts of medical trials provide very detailed information about the patients’ health conditions. On the contrary, almost no vital data such as marital status or age distribution are usually given. Yet, some of these factors can have a notable impact on the overall death rate, thereby...

Literature claims for a deeper understanding of which processes shape the evolution of network structures over time. Drawing on the assumption that the “normative ideal” network structure should be understood according to the context in which the network is embedded, we observe collaborative...

The World Trade Organisation's Trade Related Intellectual Property Rights [TRIPS] agreement aimed to harmonise intellectual property rights and patent protection globally. In India, the signing of this agreement resulted in a sharp increase in clinical trials since 2005. The Indian government,...